Clinical Trial Update: Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80 [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating DHT-Gel for symptoms of low testosterone in men aged 55-80 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Late-onset Hypogonadism
• Low Testosterone

Drugs mentioned

• DHT-Gel

Snippet

Sponsor: ASCEND Therapeutics | Conditions: Hypogonadism, Late Onset Hypogonadism | Phase 2 | Status: COMPLETED